Log in to save to my catalogue

Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for...

Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6352810

Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for atrial fibrillation

About this item

Full title

Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for atrial fibrillation

Author / Creator

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ case reports, 2019-01, Vol.12 (1), p.e227705

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Dofetilide is a class III antiarrhythmic drug that has proven efficacious in maintaining sinus rhythm in up to 60% of patients with persistent atrial fibrillation. Dofetilide’s most concerning adverse effect is QT prolongation and polymorphic VT, but providers should be aware of other rare significant side effects. We report a case of dofetilide as...

Alternative Titles

Full title

Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for atrial fibrillation

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6352810

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6352810

Other Identifiers

ISSN

1757-790X

E-ISSN

1757-790X

DOI

10.1136/bcr-2018-227705

How to access this item